Endothelial NO/cGMP System Contributes to Natriuretic Peptide-Mediated Coronary and Peripheral Vasodilation

Akiho, 1995, Interaction between atrial natriuretic peptide and vasoactive intestinal peptide in guinea pig cecal smooth muscle, Gastroenterology, 109, 1105, 10.1016/0016-5085(95)90568-5 Brunner, 1995, Tissue endothelin-1 levels in perfused rat heart following stimulation with agonists and in ischaemia and reperfusion, J. Mol. Cell. Cardiol., 27, 1953, 10.1016/0022-2828(95)90017-9 Brunner, 1996, Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery, J. Pharmacol. Exp. Ther., 277, 48 Brunner, 1998, Contribution of the endothelium to transcapillary insulin transport in rat isolated perfused hearts, Diabetes, 47, 1127, 10.2337/diabetes.47.7.1127 Chen, 1998, C-type natriuretic peptide: The endothelial component of the natriuretic peptide system, J. Cardiovasc. Pharmacol., 32, S22 De Bold, 1991, A decade of atrial natriuretic factor research, Can. J. Physiol. Pharmacol., 69, 1480, 10.1139/y91-222 Drewett, 1995, Natriuretic peptide receptor-B (guanylyl cyclase-B) mediates C-type natriuretic peptide relaxation of precontracted rat aorta, J. Biol. Chem., 270, 4668, 10.1074/jbc.270.9.4668 Garthwaite, 1995, Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, Mol. Pharmacol., 48, 184 Imura, 1992, Inhibition by HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptide-induced relaxation of isolated rabbit aorta through the blockade of guanylyl cyclase-linked receptors, Mol. Pharmacol., 42, 982 Kojda, 1997, Inhibition of nitric oxide synthase and soluble guanylate cyclase induces cardiodepressive effects in normal rat hearts, Eur. J. Pharmacol., 334, 181, 10.1016/S0014-2999(97)01168-0 Leitman, 1986, Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in cultured endothelial cells, J. Biol. Chem., 261, 11650, 10.1016/S0021-9258(18)67292-8 Murohara, 1996, Interactions of nitrovasodilators, atrial natriuretic peptide and endothelium-derived nitric oxide, J. Vasc. Res., 33, 78, 10.1159/000159135 Nakamura, 1999, Peripheral vascular remodeling in chronic heart failure: Clinical relevance and new conceptualization of its mechanisms, J. Cardiac Fail., 5, 127, 10.1016/S1071-9164(99)90035-0 Nakamura, 1994, Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure, Circulation, 90, 1210, 10.1161/01.CIR.90.3.1210 Rapoport, 1985, Effects of atrial natriuretic factor, sodium nitroprusside, and acetylcholine on cyclic GMP levels and relaxation in rat aorta, Eur. J. Pharmacol., 115, 219, 10.1016/0014-2999(85)90694-6 Redmond, 1990, Atrial natriuretic factor recognizes two receptor subtypes in endothelial cells cultured from bovine pulmonary artery, FEBS Lett., 269, 157, 10.1016/0014-5793(90)81143-C Ruskoaho, 1992, Atrial natriuretic peptide: Synthesis, release, and metabolism, Pharmacol. Rev., 44, 479 Schrammel, 1996, Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase, Mol. Pharmacol., 50, 1 Scivoletto, 1984, Cardionatrin causes vasodilation in vitro which is not dependent on the presence of endothelial cells, Eur. J. Pharmacol., 101, 143, 10.1016/0014-2999(84)90040-2 Stingo, 1992, Cardiovascular and renal actions of C-type natriuretic peptide, Am. J. Physiol., 262, H308 Suga, 1992, Characterization of natriuretic peptide receptors in cultured cells, Hypertension (Dallas), 19, 762, 10.1161/01.HYP.19.6.762 Sugamori, 1999, Atrial natriuretic peptide has nitric oxide-mediated vasodilatory effect?, Circulation, 100 Treasure, 1993, The dysfunctional endothelium in heart failure, J. Am. Coll. Cardiol., 22, A129, 10.1016/0735-1097(93)90476-H von Geldern, 1990, Atrial natriuretic peptide antagonists: Biological evaluation and structural correlations, Mol. Pharmacol., 38, 771 Wei, 1993, Action of C-type natriuretic peptide in isolated canine arteries and veins, Am. J. Physiol., 264, H71 Wei, 1994, Vascular actions of C-type natriuretic peptide in isolated porcine coronary arteries and coronary vascular smooth muscle cells, Biochem. Biophys. Res. Commun., 205, 765, 10.1006/bbrc.1994.2731 Wei, 1994, Atrial natriuretic peptide and CNP in spontaneously hypertensive rats and their vasorelaxing action in vivo, Hypertension, 23, 903, 10.1161/01.HYP.23.6.903 Wright, 1996, C-type natriuretic peptide-mediated coronary vasodilation: Role of the coronary nitric oxide and particulate guanylate cyclase systems, J. Am. Coll. Cardiol., 28, 1031, 10.1016/S0735-1097(96)00241-0